XT
BLTE

XTX Topco’s Belite Bio BLTE Stock Holding History

XTX Topco’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Buy
+15,058
New +$2.53M 0.04% 699
2025
Q1 		– Sell
-7,062
Closed -$446K – 2437
2024
Q4 		$446K Buy
7,062
+1,668
+31% +$110K 0.04% 868
2024
Q3 		$253K Buy
+5,394
New +$261K 0.02% 1305

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

XTX Topco's BLTE Position: Q1 2026 in Review

XTX Topco opened a new position in Belite Bio (BLTE) in Q1 2026: 15,058 shares worth $2.4M. The stake represents 0.04% of the portfolio and ranks #699 among its holdings. This is a return to the name: XTX Topco previously reported a position in BLTE as recently as Q4 2024.

XTX Topco first reported a position in BLTE in Q3 2024 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • XTX Topco held 15,058 shares of Belite Bio worth $2.4M as of Q1 2026.
  • Belite Bio was a new XTX Topco position in Q1 2026.
  • Belite Bio made up 0.04% of XTX Topco's portfolio in Q1 2026, its #699 holding.
  • XTX Topco first reported a position in Belite Bio in Q3 2024 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.